# DIBBS #SPE2DP-26-T-5359

DLA request for three vials of dantrolene sodium injection

**Posted:** September 30, 2026
**Respond By:** October 05, 2026
**Identifier:** SPE2DP-26-T-5359
**NAICS:** 424210

DLA Troop Support is seeking a small, expedited supply of dantrolene sodium injection for medical logistics.
- **Government buyer:** Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharm FSA; buyer contact: Timothy McCauley.
- **Request:** 3 vials of dantrolene sodium injection, USP, 250 mg per vial (20 mL), NSN 6505-01-653-1569; approved-source NDC 42367-0540-32.
- **OEM:** **Eagle Pharmaceuticals, Inc.** is the named manufacturer associated with the approved-source NDC (CAGE 7LL94). Other named approved-source vendors are Cardinal Health, Inc. (CAGE 00E55) and AmerisourceBergen Drug Corp. (CAGE 1XUY5).
- **Requirements:** FDA-regulated product; store unreconstituted at 20–25°C and protect from light. Required shelf life is 24 months and is non-extendable.
- **Delivery:** Within 5 days after award to the designated medical logistics consignee at Fort Bragg, North Carolina.

### Description

DANTROLENE SODIUM F (QTY: 3, NSN: 6505-01-653-1569, Purchase Request: 7015989572)
  Approved Sources:
  - CAGE: 00E55, Part No: NDC42367-0540-32, Company: CARDINAL HEALTH, INC.
  - CAGE: 1XUY5, Part No: NDC42367-0540-32, Company: AMERISOURCEBERGEN DRUG CORP
  - CAGE: 7LL94, Part No: NDC42367-0540-32
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP26T5359)